Jubilant Cadista recalls Pantoprazole 40mg tablets with dark brown discoloration
Jubilant Cadista recalls 40mg Pantoprazole tablets with dark brown discoloration on edges. This CGMP deviation may affect product quality but does not indicate immediate safety risks.
Lower-risk recall
CGMP Deviation: Presence of dark brown discoloration on edges of tablets.
Contact the company
What happened, in plain English
Jubilant Cadista is recalling 40mg Pantoprazole Sodium Delayed Release Tablets that show dark brown discoloration on tablet edges. This issue stems from a manufacturing deviation that could affect product quality but does not pose immediate safety risks. Read more at govinfonow.com/recall/38025-jubilant-cadista-recalls-pantoprazole-40mg-tablets-with-dark-brown-discoloration.
Source Summary by GovInfoNow · govinfonow.com/recall/38025-jubilant-cadista-recalls-pantoprazole-40mg-tablets-with-dark-brown-discoloration · Updated October 5, 2026 · FDA enforcement record: FDA #D-0145-2020
Cite this page
“Jubilant Cadista recalls Pantoprazole 40mg tablets with dark brown discoloration.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38025-jubilant-cadista-recalls-pantoprazole-40mg-tablets-with-dark-brown-discoloration. Based on FDA recall #D-0145-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0145-2020%22&limit=1).
Why it’s dangerous
The tablets show dark brown discoloration on their edges due to a manufacturing deviation. This indicates a potential issue with the product's quality but does not mean the tablets are unsafe or cause harm when taken as directed.
Who’s affected
Prescription patients who received the recalled 40mg Pantoprazole tablets with dark brown discoloration on edges. Those most at risk are patients using the product for acid reflux or ulcers.
How to tell if you have this one
Check for dark brown discoloration on the edges of 40mg Pantoprazole tablets in 90-count bottles. The product was manufactured by Jubilant Generics Ltd in India and marketed by Jubilant Cadista Pharmaceuticals Inc. in the US.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Check for discoloration
Inspect the tablets for dark brown discoloration on the edges. If present, do not use the product.
Where it went and when
Where it was distributed
Distributed in 4 states and Puerto Rico.
FDA distribution: “Product was distributed to MS, OH, RI, TN and Puerto Rico to distributors and wholesalers who may have further distributed the product to the retail level.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Mississippi, Ohio, Puerto Rico, Rhode Island, Tennessee.
Recall timeline
FDA terminated this recall 5 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0145-2020 (September 4, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0145-2020 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.